Waiving in vivo studies for monoclonal antibody biosimilar development: National and global challenges. (10th October 2016)

Record Type:: Journal Article
Title:: Waiving in vivo studies for monoclonal antibody biosimilar development: National and global challenges. (10th October 2016)
Main Title:: Waiving in vivo studies for monoclonal antibody biosimilar development: National and global challenges
Authors:: Sewell, F.
Abstract:
Is Part Of:: Toxicology letters. Volume 259(2016)Supplement
Journal:: Toxicology letters
Issue:: Volume 259(2016)Supplement
Issue Display:: Volume 259, Issue 1 (2016)
Year:: 2016
Volume:: 259
Issue:: 1
Issue Sort Value:: 2016-0259-0001-0000
Page Start:: S229
Page End:
Publication Date:: 2016-10-10
Subjects:: Toxicology -- Periodicals
363.179
Journal URLs:: http://www.sciencedirect.com/science/journal/03784274 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.toxlet.2016.07.548 ↗
Languages:: English
ISSNs:: 0378-4274
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 8873.042000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 61.xml